News for Healthier Living

Researchers Identify Target to Overcome Treatment Resistance in Preclinical Models of KRAS-Mutant Cancers

* Researchers identified that RASH3D19 creates a positive feedback loop that drives hyperactivity of RAS signaling and leads to tumor growth and treatment resistance * Reducing RASH3D19 also reduced tumor growth and sensitized cancer cells to KRAS inhibitors * Combining RASH3D19 blockers with KRAS inhibitors improved outcomes in preclinical models

December 3, 2025


December 4 2025

December 3 2025

December 2 2025

December 1 2025

November 30 2025

November 29 2025

November 28 2025

November 27 2025

November 26 2025

November 25 2025

November 24 2025

November 23 2025

November 22 2025

November 21 2025

November 20 2025